Total Payments
$11,762
2024 Payments
$1,281
Companies
53
Transactions
811
Medicare Patients
13,018
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$11,561 (98.3%)
Education$200.37 (1.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,561 | 806 | 98.3% |
| Education | $200.37 | 5 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,674 | 197 | $0 (2024) |
| ABBVIE INC. | $1,764 | 115 | $0 (2024) |
| UCB, Inc. | $821.11 | 53 | $0 (2024) |
| Lilly USA, LLC | $754.15 | 53 | $0 (2024) |
| PFIZER INC. | $703.98 | 51 | $0 (2024) |
| GlaxoSmithKline, LLC. | $524.62 | 34 | $0 (2024) |
| Janssen Biotech, Inc. | $519.76 | 38 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $446.57 | 32 | $0 (2024) |
| Genentech USA, Inc. | $384.74 | 25 | $0 (2021) |
| Radius Health, Inc. | $375.82 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,281 | 78 | Amgen Inc. ($345.11) |
| 2023 | $2,078 | 127 | Amgen Inc. ($383.01) |
| 2022 | $1,655 | 115 | Amgen Inc. ($390.76) |
| 2021 | $1,912 | 123 | Amgen Inc. ($397.63) |
| 2020 | $1,402 | 94 | Amgen Inc. ($419.41) |
| 2019 | $1,212 | 99 | AbbVie, Inc. ($247.36) |
| 2018 | $1,385 | 121 | Amgen Inc. ($246.60) |
| 2017 | $837.78 | 54 | Amgen Inc. ($295.21) |
All Payment Transactions
811 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: VACCINE | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: VACCINE | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Dermatology | ||||||
| 10/18/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Hepatitis B Vaccine | ||||||
| 10/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Endocrinology | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 3,230 | 29,520 | $1.6M | $461,616 |
| 2022 | 36 | 3,003 | 42,138 | $1.5M | $523,435 |
| 2021 | 38 | 3,378 | 43,032 | $1.0M | $532,370 |
| 2020 | 36 | 3,407 | 41,988 | $986,855 | $492,177 |
Total Patients
13,018
Total Services
156,678
Medicare Billing
$2.0M
Procedure Codes
145
All Medicare Procedures & Services
145 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 103 | 10,500 | $682,500 | $191,617 | 28.1% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 16 | 13,020 | $371,070 | $99,250 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 373 | 779 | $155,800 | $66,810 | 42.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 181 | 181 | $56,110 | $20,425 | 36.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 33 | 215 | $67,725 | $19,480 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 185 | $24,975 | $11,785 | 47.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 326 | 700 | $73,500 | $7,186 | 9.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 419 | 839 | $16,780 | $7,032 | 41.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 138 | 197 | $27,580 | $5,641 | 20.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 237 | 553 | $22,120 | $4,202 | 19.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 22 | 164 | $32,800 | $3,446 | 10.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $3,355 | $3,102 | 92.5% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 301 | 613 | $17,164 | $3,080 | 17.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 117 | 280 | $14,000 | $2,784 | 19.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 92 | 92 | $8,055 | $2,673 | 33.2% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 291 | 599 | $11,980 | $1,570 | 13.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $3,800 | $1,399 | 36.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $2,970 | $1,372 | 46.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $1,530 | $1,295 | 84.6% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 33 | 53 | $3,393 | $1,060 | 31.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 18 | 18 | $3,600 | $779.84 | 21.7% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 27 | 27 | $2,889 | $743.75 | 25.7% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 23 | 36 | $2,137 | $723.72 | 33.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $679.00 | $648.89 | 95.6% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 19 | 29 | $2,244 | $637.21 | 28.4% |
About Dr. Kristen Erickstad, MD
Dr. Kristen Erickstad, MD is a Rheumatology healthcare provider based in Longview, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2011. The National Provider Identifier (NPI) number assigned to this provider is 1972894616.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristen Erickstad, MD has received a total of $11,762 in payments from pharmaceutical and medical device companies, with $1,281 received in 2024. These payments were reported across 811 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($11,561).
As a Medicare-enrolled provider, Erickstad has provided services to 13,018 Medicare beneficiaries, totaling 156,678 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 145 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Longview, TX
- Active Since 04/28/2011
- Last Updated 09/23/2019
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1972894616
Products in Payments
- Enbrel (Biological) $1,581
- RINVOQ (Biological) $771.79
- Cimzia (Drug) $762.74
- XELJANZ (Drug) $588.10
- TALTZ (Drug) $531.71
- EVENITY (Biological) $452.62
- BENLYSTA (Biological) $389.92
- COSENTYX (Biological) $386.15
- Prolia (Biological) $363.60
- ORENCIA (Biological) $324.82
- SAPHNELO (Biological) $315.15
- Tymlos (Biological) $272.04
- Humira (Biological) $269.38
- Kerendia (Drug) $267.24
- Otezla (Drug) $254.74
- KRYSTEXXA (Biological) $246.43
- TREMFYA (Drug) $230.47
- Rituxan (Biological) $194.16
- Actemra (Biological) $190.58
- SKYRIZI (Biological) $189.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.